348 related articles for article (PubMed ID: 18984856)
1. Varenicline-associated acute renal failure.
Bird ML; Vesta KS
Ann Pharmacother; 2008 Dec; 42(12):1908-11. PubMed ID: 18984856
[TBL] [Abstract][Full Text] [Related]
2. Acute hepatic injury associated with varenicline in a patient with underlying liver disease.
Franck AJ; Sliter LR
Ann Pharmacother; 2009 Sep; 43(9):1539-43. PubMed ID: 19638471
[TBL] [Abstract][Full Text] [Related]
3. Worsening psychosis induced by varenicline in a hospitalized psychiatric patient.
DiPaula BA; Thomas MD
Pharmacotherapy; 2009 Jul; 29(7):852-7. PubMed ID: 19558259
[TBL] [Abstract][Full Text] [Related]
4. Smoking cessation with varenicline, a selective alpha4beta2 nicotinic receptor partial agonist: results from a 7-week, randomized, placebo- and bupropion-controlled trial with 1-year follow-up.
Nides M; Oncken C; Gonzales D; Rennard S; Watsky EJ; Anziano R; Reeves KR
Arch Intern Med; 2006 Aug 14-28; 166(15):1561-8. PubMed ID: 16908788
[TBL] [Abstract][Full Text] [Related]
5. Varenicline for smoking cessation: a placebo-controlled, randomized study.
Wang C; Xiao D; Chan KP; Pothirat C; Garza D; Davies S
Respirology; 2009 Apr; 14(3):384-92. PubMed ID: 19192221
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of the novel selective nicotinic acetylcholine receptor partial agonist, varenicline, for smoking cessation.
Oncken C; Gonzales D; Nides M; Rennard S; Watsky E; Billing CB; Anziano R; Reeves K
Arch Intern Med; 2006 Aug 14-28; 166(15):1571-7. PubMed ID: 16908789
[TBL] [Abstract][Full Text] [Related]
7. Varenicline: a selective alpha4beta2 nicotinic acetylcholine receptor partial agonist approved for smoking cessation.
Lam S; Patel PN
Cardiol Rev; 2007; 15(3):154-61. PubMed ID: 17438382
[TBL] [Abstract][Full Text] [Related]
8. Varenicline in smoking cessation.
Tonstad S; Rollema H
Expert Rev Respir Med; 2010 Jun; 4(3):291-9. PubMed ID: 20524911
[TBL] [Abstract][Full Text] [Related]
9. Effects of varenicline in adult smokers: a multinational, 24-week, randomized, double-blind, placebo-controlled study.
Bolliger CT; Issa JS; Posadas-Valay R; Safwat T; Abreu P; Correia EA; Park PW; Chopra P
Clin Ther; 2011 Apr; 33(4):465-77. PubMed ID: 21635992
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of varenicline for smoking cessation.
Hays JT; Ebbert JO; Sood A
Am J Med; 2008 Apr; 121(4 Suppl 1):S32-42. PubMed ID: 18342165
[TBL] [Abstract][Full Text] [Related]
11. Utilization of the smoking cessation medicine varenicline: an intensive post-marketing study in New Zealand.
Harrison-Woolrych M; Ashton J
Pharmacoepidemiol Drug Saf; 2010 Sep; 19(9):949-53. PubMed ID: 20602347
[TBL] [Abstract][Full Text] [Related]
12. Practical implementation of varenicline as an aid to smoking cessation in clinical practice.
Tonstad S
Pneumologia; 2009; 58(3):167-74. PubMed ID: 19817313
[TBL] [Abstract][Full Text] [Related]
13. [New drugs; varenicline].
van Bronswijk H; Dubois EA; Zitman FG; Cohen AF
Ned Tijdschr Geneeskd; 2007 Nov; 151(45):2503-4. PubMed ID: 18062594
[TBL] [Abstract][Full Text] [Related]
14. A manic episode in a 64-year-old man: an adverse effect of varenicline.
Ahmed AI
Gen Hosp Psychiatry; 2011; 33(2):200.e9-200.e11. PubMed ID: 21596218
[TBL] [Abstract][Full Text] [Related]
15. [Varenicline: an aid to smoking cessation therapy].
Perez-Bogerd S; Sternon J
Rev Med Brux; 2007; 28(6):523-6. PubMed ID: 18265811
[TBL] [Abstract][Full Text] [Related]
16. [Varenicline--a new drug for smoking cessation].
Tønnesen P
Ugeskr Laeger; 2007 Nov; 169(47):4051-2. PubMed ID: 18078657
[TBL] [Abstract][Full Text] [Related]
17. Exacerbation of recurrent depression as a result of treatment with varenicline.
Popkin MK
Am J Psychiatry; 2008 Jun; 165(6):774. PubMed ID: 18519539
[No Abstract] [Full Text] [Related]
18. Varenicline for smoking cessation.
Tonstad S
Expert Rev Neurother; 2007 Feb; 7(2):121-7. PubMed ID: 17286546
[TBL] [Abstract][Full Text] [Related]
19. Interference with smoking-cessation effects of varenicline after administration of immediate-release amphetamine-dextroamphetamine.
Whitley HP; Moorman KL
Pharmacotherapy; 2007 Oct; 27(10):1440-5. PubMed ID: 17896898
[TBL] [Abstract][Full Text] [Related]
20. Human abuse liability of the smoking cessation drug varenicline in smokers and nonsmokers.
McColl SL; Burstein AH; Reeves KR; Billing CB; Stolar M; Sellers EM
Clin Pharmacol Ther; 2008 Apr; 83(4):607-14. PubMed ID: 18288085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
